downloadGroupGroupnoun_press release_995423_000000 copyGroupnoun_Feed_96767_000000Group 19noun_pictures_1817522_000000Member company iconResource item iconStore item iconGroup 19Group 19noun_Photo_2085192_000000 Copynoun_presentation_2096081_000000Group 19Group Copy 7noun_webinar_692730_000000Path
Skip to main content
Default Banner Image

On-Demand

Registration

SEMI Members:  $49

Use your corporate email address during log in to be recognized as a SEMI Member.

Non-Members:  $75

Students:  Free

Contact [email protected] with a picture of your student ID to receive your discount code.

Belgium France Germany Ireland Italy United States FEMC 18 Tile Recorded Business Executive Featured Speakers
Highlighted content

Bio

The Department of Defense needs non-linear advances in gas-phase sensing to identify chemical threats, toxic industrial compounds, and physiological changes present in human breath. Currently, fieldable instruments for gas analysis are large (>0.5 cubic feet), expensive (>$50,000), and slow. Hand-held devices are limited to identification of specific targets such as nitrogen oxide, oxygen, and carbon dioxide or generalized estimated concentration of total volatile organic compounds (VOCs). Biohybrid sensing involves combining biological sensory elements with electronic components in a SWaP-C solution for fast and accurate detection of VOCs. Unprecedented VOC sensing potential lies within the biological sense of olfaction, which boasts rapid, selective, and sensitive capability to identify hundreds of thousands of compounds in complex environments. However, there are currently no commercially available devices harnessing the capability of olfaction due to the challenges in the bioelectronic interfacing necessary for maintaining long-term stability and environmental conditions necessary to sustain olfactory signaling elements (whether it be at the organ-, cell-, or protein-level). This course will provide an overview of the current state of biohybrid VOC sensing comparing and contrasting examples utilizing olfactory organ/tissue-based, cell-based, and protein-based modalities.

ABOUT THE SPEAKER

Dr. Elisabeth Steele is a biomedical engineer at Blue Halo serving as a Lead Scientist and Team Lead supporting sensor development at the Air Force Research Laboratory (AFRL). Her expertise is in neural tissue engineering and electrophysiology with recent focus in the design and testing of biohybrid gas sensors inspired by insect olfaction. Dr. Steel conducted neuromodulation research as a post-doctoral fellow with Dr. Tim Bruns at the University of Michigan. Additionally, she served as a Technical Sales Engineer with NeuroNexus Technologies, the industry leader in microelectrode array technology for neuroscience electrophysiology applications. She received her PhD (2018) and M.S. (2013) in Biomedical Engineering from Wayne State University in Detroit, Michigan. She completed her B.S. in Bioengineering in 2007 from University of Toledo.  
 

United States

Dr. Elisabeth Steele
Dr. Elisabeth Steele
Lead Scientist and Team Lead
UES
Gity Samadi
Dr. Gity Samadi
Director, R&D Programs
SEMI
FlexTech

This webinar features Dr. Elisabeth Steele of UES covering the status of non-linear advances in gas-phase sensing to identify chemical threats, toxic industrial compounds, and physiological changes present in human breath.

10:00 am - 12:00 pm Off Add to Calendar Disabled America/Los_Angeles Watch Now!
Event format
Promote in calendar
Off

Registration

SEMI Members:  $49

Use your corporate email address during log in to be recognized as a SEMI Member.

Non-Members:  $75

Students:  Free

Contact [email protected] with a picture of your student ID to receive your discount code.

Belgium France Germany Ireland Italy United States FEMC 17 Tile Recorded Business Executive Featured Speakers
Highlighted content

Bio

The healthcare industry has transformed over the last twenty-five years due to the co-development of diagnostics along with state-of-the-art therapeutics and treatments; notably, this has led to the field of companion diagnostics. The best example of this is the prescribed use of insulin based on glucose levels monitored via test strips or the continuous glucose monitor. The future goal of medicine is to have truly personalized treatment protocols based on an individual’s biometrics, physiology, and exposure.  

However, this goal requires further identification and quantitation of biomarkers and health exposures, both biological and chemical, both at the point-of-care as well as in real-time.  Therefore, technologies are needed that can miniaturize current diagnostics to make them inexpensive, simple-to-use, and ideally wearable. 

However, where and what to sense remains a critical question to solve, as each biofluid, including blood, sweat, saliva, tears, breath, and exhaled breath condensate contains a different profile of biomarkers. Additionally, biomarkers have vastly different physiochemical properties and abundances, which present different challenges as well as require a range of sensing modalities.  Therefore, this course will be an overview of the “What, Where, and How of Sensing to Meet Current and Future MedTech Needs”.  At the end of the course, a perspective of where these technologies can impact the future of health outcomes will be presented as well as key considerations for future technologies to gain commercial acceptance

ABOUT THE SPEAKER

Dr. Michael Brothers, PMP currently is a Principal Scientist and Technical Program Manager at UES, a Blue Halo Company. In these roles, Dr. Brothers supervises contractors executing research to identify biomarkers indicative of human performance, develop novel sensors, as well as field research. Dr. Brothers also serves as a subject matter expert on biochemical sensors, both in the liquid phase and gas phase, for the 711th Human Performance Wing at Wright Patterson Air Force Base. 

Notably, Dr. Brothers has co-authored multiple publications and patents on using novel sensing modalities to sense in complex fluids and environments, including jet fuel, sweat, saliva, and breath. Dr. Brothers has also served as the Principal Investigator on sensor development efforts for both optical based gas sensors and flexible, ink-printed gas sensors for wearable applications.  

Dr. Brothers has his Ph.D. from the University of Illinois Urbana-Champaign in Chemical Biology and his B.S. in Chemistry and Biology from the University of Cincinnati.  
 

United States

Dr. Michael Brothers
Dr. Michael Brothers
Principal Scientist and Technical Program Manager
UES, a Blue Halo Company
Gity Samadi
Dr. Gity Samadi
Director, R&D Programs
SEMI
FlexTech

This webinar featured Dr. Michael Brothers of UES, a Blue Halo Company, outlining the status of personalized medical treatment protocols based on an individual’s biometrics, physiology, and exposure. This course will be an overview of the “What, Where, and How of Sensing to Meet Current and Future MedTech Needs"

10:00 am - 12:00 pm Off Add to Calendar Disabled America/Los_Angeles Watch Now
Event format
Promote in calendar
Off

SEMI Members:  $49

Use your corporate email address during log in to be recognized as a SEMI Member.

Non-Members:  $99

Students:  Free

Contact Gity Samadi ([email protected]) with a picture of your student ID to receive your discount code. 

Flexible Hybrid Master Classes are offered on many topics!  Visit this page for entire list and links to more detailed information on each one.

Belgium China France Germany Ireland Italy Japan Malaysia Russia Singapore South Korea Taiwan United States Vietnam Watch the Master Class Now FlexTech animation Technical

OVERVIEW

In the last few years, electronics packaging has rightfully emerged from the shadows of CMOS scaling to make a significant impact in high performance and mobile appliance computing.  

In this course, we reviewed the key developments in this paradigm change and the implications these have on Flexible Hybrid Electronics especially the use of bare dielets, fine pitch interconnects and novel substrate materials.

The area of Flexible Hybrid Electronics (FHE) has also developed and is making a significant impact in the area of medical and wellness electronics.  The first generation of these devices have, for most part, adapted Printed Circuit Board (PCB) technology by using thinner PCBs and assembling either thinned or thin packaged “older” generation of chips on to these platforms, typically with coarse printed wiring to connect a small number of such chips.

This approach, while immensely useful to get  the field going, needs to adapt and borrow from the both silicon and advanced packaging technology trends, so that we can advance this trend to the next level. The key paradigm challenges ahead are: scaling  FHE in general – this includes the adoption of dielet (chiplet) technology in more advanced CMOS nodes including edge-AI, higher performance interconnects, flexible high-density energy storage, wireless communication and advanced ergonomics and all of these at lower cost and higher reliability.

This talk addresses the challenges and outline a possible technology roadmap to achieve these goals in the next few years.

Featured Speaker Biography: Subramanian S. Iyer (Subu) is Distinguished Professor and holds the Charles P. Reames Endowed Chair in the Electrical Engineering Department and a joint appointment in the Materials Science and Engineering Department at the University of California at Los Angeles. He is Director of the Center for Heterogeneous Integration and Performance Scaling (CHIPS). Prior to that he was an IBM Fellow. His key technical contributions have been the development of the world’s first SiGe base HBT, Salicide, electrical fuses, embedded DRAM and 45nm technology node used to make the first generation of truly low power portable devices as well as the first commercial interposer and 3D integrated products. He also was among the first to commercialize bonded SOI for CMOS applications through a start-up called SiBond LLC.

More recently, he has been exploring new packaging paradigms and device innovations that they may enable wafer-scale architectures, in-memory analog compute and medical engineering applications. He has published over 300 papers and holds over 75 patents. He has received several outstanding technical achievements and corporate awards at IBM. He is an IEEE Fellow, an APS Fellow, an iMAPS Fellow and a Distinguished Lecturer of the IEEE EDS and EPS and a member of the Board of Governors of IEEE EPS. He is also a Fellow of the National Academy of Inventors. He is a Distinguished Alumnus of IIT Bombay and received the IEEE Daniel Noble Medal for emerging technologies in 2012 and the 2020 iMAPS Daniel C. Hughes Jr Memorial award.

Read More About Dr. Subramanian Iyer

On-Demand, Online
United States

Subramanian S. Iyer
Subramanian S. Iyer, PhD
Distinguished Chancellor's Professor & Charles P. Reames Endowed Chair
UCLA
- FlexTech Standards

View this Master Class On Demand!  Learn why and how new packaging paradigms like chiplets and dielets are impacting the world of flexible hybrid electronics (FHE) from one of the industry's foremost experts, Dr. Subramanian Iyer of UCLA.  The course explores how these packages are packing such a punch and enabling advanced performance in a much smaller and flexible footprint.

10:00 am - 12:00 pm Off Add to Calendar Disabled
Event format
Promote in calendar
Off